Cite
HARVARD Citation
Rymut, S. et al. (2023). A mechanistic PK/PD model to enable dose selection of the potent anti‐tryptase antibody (MTPS9579A) in patients with moderate‐to‐severe asthma. Clinical and translational science. 16 (4), pp. 694-703. [Online].